Insulet Beats Sales and EPS Estimates Despite Slightly Lowering 2026 Outlook

SentiSense · Published · Updated

Insulet reported Q2 sales of $801.7M, exceeding FactSet estimates of $787.4M and Q2 EPS of $1.66 per share, a 21c beat. However, the company slightly ...

Sign in to read the full story. Free accounts include 20 full reads a month.

Sign in or create a free account

Powered by SentiSense - Intelligent Market Analysis